Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dynamic Monitoring of Circulating Tumor DNA (ctDNA) and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery/Treatment

NCT06420427 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT06420427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06420427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dynamic Monitoring of Circulating Tumor DNA (ctDNA) and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery/Treatment
Lead sponsor
The Third Affiliated Hospital of Guangzhou Medical University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
January 30, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cfhpv dna in plasma of cervical cancer patients